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Background: Induction of labour (IOL) is a common procedure yet we have little information on 
the efficacy of the process for women with a hypertensive disorder of pregnancy (HDP). 
Objective: To describe the birth type and associated factors in nulliparous HDP women undergoing 
an induction of labour.  
Study design: Statutorily collected datasets on every birth and hospital admission which occurred 
in the state of NSW Australia between the years 2000-2011 were analysed. Hypertensive women 
were compared to normotensive women.  
Results: Of the nulliparous women, 9.9% had a HDP.  IOL for HDP women were 56.2% in a 
cohort of 447 558 women. The AOR for a woman with a HDP undergoing an IOL resulting in a 
vaginal delivery when compared to a normotensive woman is 0.86 (95%CI 0.83-0.88). Prior to 33 
weeks, the lowest perinatal mortality rates (PMR) are seen in women who undergo elective 
caesarean section (C/S). For women with preeclampsia (PE), lower PMR are seen in women who 
undergo IOL.   
Conclusion: For women with PE and SPE, IOL resulted in lower rates of vaginal delivery than 
spontaneous labour when compared to normotensive women who also underwent IOL. Women 
with PE at ≥33 weeks who underwent IOL had the lowest PMR.  






 Induction of labour (IOL) through the use of prostaglandins, syntocinon and amniotomy are 
common procedures in industrialised countries. Rates of induction and associated morbidity are 
both increasing [1] and it is known that elective induction for non-medical reasons increases the 
risk of adverse events in both mothers and babies [2]. From Level 1 evidence we know that the 
process may be feasible in outpatient settings for low risk women [3, 4], that women prefer the 
process to commence in the morning, although there is no increased efficacy when compared to 
evening commencement [4, 5]. The process may prevent infant macrosomia in the babies of insulin 
dependent diabetic women [6], although there is no evidence to support the process as preferable 
when compared to repeat elective caesarean section in women with previous caesarean section [7], 
but the induction process in all women may be of benefit in preventing perinatal death in women at 
or beyond term [8]. There is not enough evidence to support the routine use of acupuncture [9], 
amniotomy alone [10], castor oil [11], corticosteroids [12], extraamniotic prostaglandins [13], 
homeopathy [14], or sexual intercourse [15] although breast stimulation may be beneficial in low 
risk women [16] and membrane sweeping [17,18] has been shown to increase spontaneous labour 
rates in low risk women at term. Hyaluronidase injections may increase vaginal birth rates [19], 
intravaginal prostaglandin administration is optimal to intracervical [20], syntocinon is optimal in 
conjunction with prostaglandin administration in comparison to syntocinon alone [21], intravenous 
prostaglandin is not more efficacious than intravenous oxytocinon and has more side effects [22], 
mechanical methods may be preferable to prostaglandins in reducing caesarean section rates [23] 




Even though we have a significant amount of evidence concerning the IOL process overall there is 
very little evidence of efficacy of the process in hypertensive women. The HYPITAT randomised 
controlled trial evaluated the efficacy of IOL in women with gestational hypertension and mild 
preeclampsia [25]. In this study women in the IOL arm had a reduced risk of the composite 
maternal outcome (serious morbidity or mortality) (relative risk 0·71, 95% CI 0·59—0·86, 
p<0·0001) when compared to women treated with expectant management with no overall 
difference in operative delivery or caesarean section rates. The study reported no increase in 
adverse neonatal outcomes but was not powered sufficiently for this outcome. HYPITAT II 
examined the effect of IOL in women 34-37 weeks gestation and found no difference in maternal 
outcomes but significantly more neonatal distress in the IOL arm [26]. The 2.5 year follow up on 
women in the HYPITAT study found no difference between the women’s cardiovascular status 
between women who underwent IOL (and were therefore exposed to short (seven days on average) 
time periods of disease) and women who delivered following expectant management [27]. 
Following the publication of these results, induction of labour in hypertensive women increased in 
the Netherlands from 58.3% to 67.1% [28].  In regard to women with severe hypertensive disease 
who require delivery to optimise either or maternal or fetal safety, there is an absence of trial data 
examining the effect of IOL in comparison to elective caesarean section at either term or pre-term 
women. Expert opinion drives clinician decision making in the majority of cases [29].  
The effectiveness of the varying methods and combination of methods of induction of labour used 




The aim of this study was to describe the birth type and associated factors in nulliparous HDP 
women undergoing an induction of labour dependent upon diagnosis and method of IOL 
undertaken. Validated population registry datasets, such as this, are able to provide a large cohort 
for analysis and enable diagnostic groupings of HDP to be examined.  
 
Materials and Methods:  
Pregnancy and birth data for the time period July 1st 2000 till December 31st 2011 of all births 
were provided by New South Wales (NSW), Ministry of Health as recorded in the NSW Perinatal 
Data Collection (PDC). This population based surveillance system contains maternal and infant 
data on all births of greater than 400 grams birth weight and/or 20 completed weeks gestation. The 
NSW PDC contains statistics on all births in New South Wales - which amounts to one third of all 
births which occur in Australia annually. Data is provided on a variety of variables including 
maternal age, maternal hypertension, maternal diabetes, parity, fetal presentation, onset of labour, 
gestation at birth, delivery type, Apgar scores and admission to neonatal intensive care and 
resuscitation details for the neonate. This dataset (NSW PDC) was linked to the Admitted Patient 
Data Collection (APDC) for the same time period through the New South Wales Centre for Health 
Record Linkage (CheReL). Probabilistic data linkage techniques were utilised for data linkage and 
de-identified datasets were provided for analysis. Probabilistic record linkage software assigns a 
'linkage weight' to pairs of records. For example, records that match perfectly or nearly perfectly 
on first name, surname, date of birth and address have a high linkage weight, and records that 




the records truly match, and if the linkage weight is low it is likely that the records are not truly a 
match. This technique has been shown to have a false positive rate of 0.3% of records [30].  
Ethical approval was obtained from the NSW Population and Health Services Research Ethics 
Committee, Protocol No.2010/12/291.  
 
Subjects:   
There are four types of hypertension recognised within the diagnostic criteria prescribed by the 
Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) [31]. Women were 
coded as having preeclampsia if their PDC record was coded for the variable ‘Pre-eclampsia’, or 
‘Pregnancy Induced Hypertension – proteinuric’ (variable available 2006-2011) or if their APDC 
record for the birth record was coded as including the International Statistical Classification of 
Diseases (ICD-10-AM) [32] codes O14.0, O14.1, O14.2, O14.9 (proteinuric hypertension). Cases 
of gestational hypertension were derived from the PDC code ‘Pregnancy Induced Hypertension – 
non-proteinuric’ or if their APDC record for the birth event was coded as including ICD-10-AM  
code O13.0 (gestational hypertension). Cases of chronic hypertension were derived from either the 
PDC, where a positive response was recorded for chronic hypertension or from the APDC records 
of women who had a birth admission which included the ICD-10-AM codes O10.0, O10.1, O10.2, 
O10.3, O10.4, O10.9 (chronic hypertension). Cases of preeclampsia superimposed on chronic 
hypertension were derived where a PDC record had a positive response for both preeclampsia and 




the ICD-10-AM code O11 (superimposed preeclampsia on chronic hypertension). In cases where 
the type of hypertension differed between that recorded on the PDC and the APDC, the diagnosis 
considered more severe was used, for example a women coded as having gestational hypertension 
in one system and preeclampsia in the other was given a final diagnosis of preeclampsia. Women 
who received none of these hypertensive codes were coded as normotensive. The birth admission 
including the ICD-10-AM codes Z37.0 (single live birth), Z37.1 (single stillbirth) or Z38.0 
(singleton born in hospital) was deemed the birth admission in the APDC dataset.  Death may have 
been detected on any one of the following four datasets. The PDC ‘Discharge status’ variable or 
admissions in the APDC where the case mode separation was coded as ‘Died’ or the NSW RBDM 
or ABS Death Data where a death had been recorded. 
Nulliparous women with a singleton pregnancy were only included in this study to eliminate the 
potential effect of previous delivery type and plurality. 
 
Outcomes: 
Stillbirth and neonatal deaths were calculated from multiple sources but were limited to those that 
occurred within 28 days of birth and they were only counted once. The maternal admission data for 
any admission that occurred during the pregnancy, as well as the birth admission for all cases of 
stillbirth or neonatal death were examined to determine any maternal medical or pregnancy related 
condition. This methodology of utilising multiple data sources to identify cases has been shown by 




Gestation is recorded at birth in the PDC and is also recorded in the database according to the 
woman's menstrual history, usually combined with a routine scan at 12-13 weeks. Onset of labour 
(spontaneous, induced or no labour) was as recorded in the PDC. The PDC also provided the 
delivery type data as well as neonatal outcomes, such as admission to neonatal intensive care 
(NICU) or special care nursery (SCN), resuscitation, APGAR scores, birth weight, as well as 
reason for caesarean section. Fetal distress was as recorded in the birth record in the APDC 
utilising the ICD-10-AM codes O68 – labour and delivery complicated by fetal stress. Vaginal 




Demographic data is reported between the comparison groups according to HDP status utilising 
Chi square for dichotomous variables and mean or median comparison for continuous data. When 
examining delivery type, odds ratios were calculated using logistic regression with and without 
adjustment for maternal age and gestation at delivery. Taking into account the size of the cohort 
and the number of analyses undertaken, results were considered significant at the level p<0.01. 






Within the time period (2000-2011) there were 669 880 deliveries. This number was refined to 447 
558 nulliparous women with a singleton pregnancy. The rate of HDP within this cohort was 9.9% 
(44 498 women).  The demographic details and birth outcomes for all nulliparous women, stratified 
for the diagnosis of HDP, are contained in Table 1. An analysis of cases defined by induction, 
including outcomes, is displayed in Table 2. An analysis of the odds ratio of an induction of labour 
resulting in a vaginal birth both unadjusted and adjusted is contained in Table 3. Table 4and 5 
contain a detailed analysis of maternal and neonatal outcomes for women and neonates undergoing 





















Age 28.7 (5.70) 28.8 (5.79) 28.7 (5.86) 28.6 (5.60) 31.6 (5.57) 28.7 (5.70) 




































































































































































































































3340 (597.69) 3199 (691.53) 2937 (848.29) 











































































































































































Vagainal birth 69.3% 59.3% 52.4% 62.8% 76.9% 70.1% 
Total 
Vaginal birth 
74 824/108 225 
69.1% 













Table 2 Induction of labour method and % resulting in vaginal birth expressed per diagnostic group as a % of women undergoing that 











Table 3 Unadjusted and adjusted 
odds ratio of an induction of labour 
resulting in a vaginal birth for both 
normotensive and hypertensive 
women adjusted for maternal age, 
gestation at delivery, maternal smoking, maternal diabetes and neonatal gender. 
  
 Vaginal birth Odds ratio Adjusted odds ratio p 
Normotensive induced women 1.00    
HDP induced women 0.87 (0.85-0.90) 0.86 (0.83-0.88) <0.001 
Preeclampsia induced women 0.79 (0.76-0.83) 0.75 (0.72-0.79) <0.001 
Gestational Hypertension induced 
women 
0.97 (0.93-1.00) 0.96 (0.93-1.00) 0.06 
Chronic Hypertension induced 
women 
0.82 (0.71-0.94) 0.88 (0.77-1.01) 0.06 
Superimposed Preeclampsia 
induced women 









 caesarean section 
n=877 (5.2%) 
Induced labour 
 vaginal birth 
n=5974 (35.4%) 




















97 (4.0%) 30 (3.4%) 286 (4.8%) 78 (2.3%) 220 (5.2%) 


















































1 (41.3/100 000) 
 
1 (114/100 000) 
 




1 (23.6/100 000) 






Reason for caesarean 
section 







Failure to progress 57.4% 48.1% 54.2% 58.0% 52.0% <0.001 
Fetal distress 28.2% 30.9% 28.7% 28.1% 32.6% <0.001 
Other 13.4% 20.2% 16.1% 13.6% 14.9% <0.001 
Not stated/missing 1.0% 0.8% 1.0% 0.3% 0.5% <0.001 





The eclampsia rate statistically differed between those HDP women who laboured spontaneously (1.4/1000), 
were induced (1.2/1000) or underwent elective pre-labour caesarean section (2.8/1000) (p=0.008). Eclamptic 
events which occurred during labour were not different between women who laboured spontaneously (0.58/1000 
HDP deliveries) and those whose labour was induced (0.52/1000 HDP deliveries) (p=0.97). Fetal distress 
occurred in 25.5% of preeclampsia cases, 23.4% of gestational hypertension cases, 25.1% of chronic 
hypertension cases and 29.2% of superimposed preeclampsia cases (p<0.001).  
 
 
For all HDP women, as well as women with preeclampsia and chronic hypertension, the IOL method which 
resulted in the highest vaginal delivery rate was prostaglandin and ARM (75.0%, 72.3% and 82.4% 
respectively). For normotensive women and women with gestational hypertension and superimposed 
preeclampsia, the method which resulted in the highest vaginal delivery rate was ARM only (77.2%, 80.3% and 
73.3% respectively). See Table 3.  
 
Rates of fetal distress in fetuses of induced women were higher in all HDP diagnostic groups than for women 
who laboured spontaneously (p<0.001) but did not differ significantly between diagnostic groups for HDP 
induced women. See Figure 1. Reason for caesarean section for induced women is illustrated in Table 6, with 






Figure 1 Rates of fetal distress as recorded in the mother’s birth record utilising ICD-10-AM codes compared 
between HDP diagnostic groups 
 
Following adjustment for gestation, maternal age, presence of maternal diabetes, smoking and neonatal gender, 
the odds ratio for a woman with preeclampsia or superimposed preeclampsia of delivering vaginally following 




The differences in gestation at birth, induction rates, birthweight, need for special care or intensive care for 
neonates clearly differentiates the hypertensive cohort as one at greater risk for adverse outcomes when 
compared to the normotensive. Women with preeclampsia deliver earlier, are induced more frequently and give 
birth to lower weight infants than normotensive women and women with gestational hypertension [34].  In this 
study hypertensive women were induced at greater than twice the rate as normotensive women (26.9 %v 56.2%) 
and this highlights the interventionist management of the HDPs in the Australian setting, where only 27.2% of 
hypertensive women labour spontaneously. In comparison to expectant management, intervention for women 
with HDP has been shown to lower both mortality and morbidity for mother and baby [35, 36, 37].   
Although women with preeclampsia have a reduced OR of delivering vaginally following IOL than 
normotensive women, this finding was not replicated in the women with gestational hypertension or chronic 
hypertension indicating that women with preeclampsia may have a reduced receptiveness to induction 




caesarean section in these women. The absence of blood pressure, pharmacological treatment and biochemical 
data in this dataset limits the conclusions which can be drawn around this issue.  
The higher rates of vaginal birth following IOL occurred in both hypertensive and normotensive women who 
delivered pre-term. There is very little in the literature assessing the safety and efficacy of the IOL process in 
hypertensive women pre-term. Those studies which have addressed this pre-term issue have not included 
hypertensive women [38-41].  Although the numbers in the HDP pre-term groups were not large (n=5456) when 
compared to the term deliveries (127 525) these numbers were still greater than any which have been reported 
previously.  
The method of induction appeared to influence the vaginal delivery rate. Differences in vaginal delivery rates as 
high as 32.4% were seen between induction methods. The absence of syntocinon usage in all HDP groups and 
normotensive women was associated with the highest rates of vaginal birth, whether it be through the use of 
prostaglandins and ARM or ARM alone. Many other factors have been indicated as influencing IOL success, 
with parous, tall women with a low BMI having higher vaginal delivery rates [42] although other factors such as 
cervical length on transvaginal ultrasound as well as the Bishops Score (most importantly the dilatation 
component) have higher positive predictive values for vaginal delivery [43, 44]. Insulin like growth factor 
binding protein 1 and fetal fibronectin also appear to play a part in predicting IOL success [44] although we were 
not able to control for these in this study.  
Maternal mortality is higher in the HDP group than the normotensive (20.2 v 3.9/100 000 births). In a systematic 
review of maternal mortality worldwide, hypertensive disease accounted for a 16.1% of maternal deaths in the 
developed world [45] with variation in rates between 6.7% and 24.3%. The 20.2/100 000 maternal mortality rate 
associated with hypertensive disease in this study equates to 27.3% of all maternal mortality (in this total cohort), 




occurred in women at ≤32 weeks gestation, 22% occurred between 33-36 weeks and the remaining 48% occurred 
at term.  In this study, none of the cases of maternal death were directly associated with women with eclampsia. 
Following removal of all known fetal deaths in utero, the women with preeclampsia who laboured spontaneously 
and delivered vaginally had the highest rates of perinatal mortality (21.5/1000 ) when compared to women who 
laboured spontaneously or were induced and delivered via caesarean section or vaginally or underwent elective 
caesarean section. The overall perinatal mortality rate in this cohort was 10/1000 births or 1% of nulliparous, 
singleton births. This equates to World Health Organisation estimates [46].  
Elective caesarean section when compared to induced or spontaneous labour was not protective against the 
incidence of eclampsia. The overall eclampsia rate per 1000 preeclamptic births was 3.1. In the spontaneous 
cohort it was 3.9/1000, in the induced cohort 2.3/1000 and the elective caesarean section cohort 4.5/1000.  Even 
if only postpartum seizures were examined, the incidence of eclampsia in the elective caesarean section cohort 
was 3.3/1000 compared to 1.1/1000 within the induced women. When comparing women with preeclampsia who 
gave birth vaginally to women who delivered via caesarean section [regardless of onset on labour], the incidence 
of eclampsia was 2.4/1000 births compared to 3.9/1000 births respectively. When examining postpartum 
eclampsia this difference was even greater with 0.6/1000 in the vaginal birth cohort and 2.5/1000 in the 
caesarean section group.  The increased incidence in women postpartum following caesarean section could be 
due to these women being more severely unwell, larger volumes of intravenous fluids being administered, 
rebound hypertension following spinal/epidural removal or the use of non-steroidal anti-inflammatory drugs 






 The adjusted odds ratio for a woman with preeclampsia or superimposed preeclampsia undergoing an induction 
of labour which results in a vaginal birth in lower than for normotensive women.Superimposed preeclampsia 
carries the highest maternal and perinatal mortality rates.  Clinicians are able to use these results as a guide 
accompanying the wide variety of clinical and laboratory findings regarding maternal and fetal well-being. 
 
Limitations and future directions: 
Large datasets are powerful tools to study incidence and associated factors. These results do not imply causation. 
The datasets used in this study lack data on maternal BMI, blood pressure readings, disease symptoms 
haematological findings, treatment variations, incidence of fetal distress, cardiotocograph and other 
measurements of fetal well-being  -  all factors which may be potential confounders in assigning causal 
associations. These data items are not recorded in the PDC nor the APDC and, hence, could not be included in 
variables in any statistical modelling. Event timeline information is also not able to be established. Multifactorial 
clinician assessment of individual cases can never be modelled into this type of equations.  These more refined 
details are able to be detected in smaller cohorts and trials yet such tools lack the power often required to answer 
specific questions which often leads to the use of composite outcomes which are neither precise nor specific. 
Large datasets which provided greater detail on baseline maternal characteristics would meet the needs of 
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- 56.2% of women with a HDP underwent an IOL during the 11 year period of the study 
- The AOR of a women with HDP undergoing an IOL resulting in a vaginal delivery was 0.86 (95% CI 0.83-0.88) when compared to normotensive 
women undergoing an IOL 
 
